GB1478469A - Ansamycin antibiotics produced by a species of micromonospora - Google Patents
Ansamycin antibiotics produced by a species of micromonosporaInfo
- Publication number
- GB1478469A GB1478469A GB3910674A GB3910674A GB1478469A GB 1478469 A GB1478469 A GB 1478469A GB 3910674 A GB3910674 A GB 3910674A GB 3910674 A GB3910674 A GB 3910674A GB 1478469 A GB1478469 A GB 1478469A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibiotic
- mixture
- atcc
- compositions
- micromonospora
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G11/00—Antibiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/863—Mycobacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
1478469 Antibiotic compositions containing ansamycins PFIZER INC 6 Sept 1974 [9 Jan 1974] 39106/74 Heading ASB [Also in Division C2] Pharmaceutical compositions having antibiotic activity comprise, as active ingredient, a mixture obtained by cultivating Micromonospora lacustris sp. nov. Routien (ATCC 21975) or a mutant strain (ATCC 21974) under submerged aerobic conditions in an aqueous nutrient medium containing an assimilable source of carbon and nitrogen until substantial antibiotic activity is obtained and separating the antibiotic products, or a component of the said mixture which is 3-methylthiorifamycin S or SV, or a hexahydro derivative of the said component, in admixture with at least one pharmaceutically acceptable carrier. The antibiotic mixture contains rifamycin S and SV. The compositions may be administered orally or parenterally as tablets, suspensions, elixirs or solutions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US431845A US3914218A (en) | 1974-01-09 | 1974-01-09 | 3-Methylthiorifamycins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1478469A true GB1478469A (en) | 1977-06-29 |
Family
ID=23713694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3910674A Expired GB1478469A (en) | 1974-01-09 | 1974-09-06 | Ansamycin antibiotics produced by a species of micromonospora |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US3914218A (en) |
| JP (1) | JPS5748198B2 (en) |
| AR (1) | AR207344A1 (en) |
| AT (1) | AT338970B (en) |
| BE (1) | BE824104A (en) |
| CA (1) | CA1033674A (en) |
| CH (1) | CH596311A5 (en) |
| CS (1) | CS191924B2 (en) |
| DD (1) | DD115917A5 (en) |
| DE (1) | DE2500898A1 (en) |
| DK (1) | DK137841B (en) |
| ES (1) | ES433631A1 (en) |
| FI (1) | FI53983C (en) |
| FR (1) | FR2256756B1 (en) |
| GB (1) | GB1478469A (en) |
| HU (1) | HU173914B (en) |
| IE (1) | IE40205B1 (en) |
| IL (1) | IL46268A (en) |
| LU (1) | LU71608A1 (en) |
| NL (1) | NL7500200A (en) |
| PL (1) | PL94189B1 (en) |
| RO (1) | RO63768A (en) |
| SE (1) | SE404376B (en) |
| SU (1) | SU575038A3 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116768910A (en) * | 2023-08-18 | 2023-09-19 | 山东齐都药业有限公司 | Refining method of rifabutin |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
| JPS5653682A (en) * | 1979-10-09 | 1981-05-13 | Kanebo Ltd | Production of novel rifamycin derivative |
| US4877735A (en) * | 1987-06-19 | 1989-10-31 | Takeda Chemical Industries, Ltd. | Process for producing 2-keto-L-gulonic acid |
| USD870945S1 (en) | 2016-07-26 | 2019-12-24 | Solar Eco Systems | Solar light |
| USD874704S1 (en) | 2016-07-26 | 2020-02-04 | Solar Eco Systems | Solar light |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1165179A (en) * | 1966-10-25 | 1969-09-24 | Lepetit Spa | Derivatives of Rifamycin SV |
-
1974
- 1974-01-09 US US431845A patent/US3914218A/en not_active Expired - Lifetime
- 1974-09-06 GB GB3910674A patent/GB1478469A/en not_active Expired
- 1974-11-12 IE IE2322/74A patent/IE40205B1/en unknown
- 1974-11-26 SE SE7414855A patent/SE404376B/en not_active IP Right Cessation
- 1974-12-17 IL IL46268A patent/IL46268A/en unknown
- 1974-12-17 CA CA216,254A patent/CA1033674A/en not_active Expired
- 1974-12-20 DK DK673174AA patent/DK137841B/en not_active IP Right Cessation
- 1974-12-30 RO RO7400081010A patent/RO63768A/en unknown
-
1975
- 1975-01-01 AR AR257231A patent/AR207344A1/en active
- 1975-01-06 CS CS7592A patent/CS191924B2/en unknown
- 1975-01-06 BE BE1006371A patent/BE824104A/en not_active IP Right Cessation
- 1975-01-06 FR FR7500227A patent/FR2256756B1/fr not_active Expired
- 1975-01-08 ES ES433631A patent/ES433631A1/en not_active Expired
- 1975-01-08 AT AT9575A patent/AT338970B/en not_active IP Right Cessation
- 1975-01-08 FI FI750038A patent/FI53983C/en not_active IP Right Cessation
- 1975-01-08 HU HU75PI443A patent/HU173914B/en unknown
- 1975-01-08 CH CH13575A patent/CH596311A5/xx not_active IP Right Cessation
- 1975-01-08 DD DD183549A patent/DD115917A5/xx unknown
- 1975-01-08 NL NL7500200A patent/NL7500200A/en not_active Application Discontinuation
- 1975-01-08 DE DE19752500898 patent/DE2500898A1/en not_active Withdrawn
- 1975-01-08 SU SU7502100888A patent/SU575038A3/en active
- 1975-01-09 JP JP50005241A patent/JPS5748198B2/ja not_active Expired
- 1975-01-09 LU LU71608A patent/LU71608A1/xx unknown
- 1975-01-09 PL PL1975177255A patent/PL94189B1/pl unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116768910A (en) * | 2023-08-18 | 2023-09-19 | 山东齐都药业有限公司 | Refining method of rifabutin |
| CN116768910B (en) * | 2023-08-18 | 2023-10-31 | 山东齐都药业有限公司 | Refining method of rifabutin |
Also Published As
| Publication number | Publication date |
|---|---|
| DK137841C (en) | 1978-10-16 |
| FR2256756B1 (en) | 1978-06-30 |
| FI53983B (en) | 1978-05-31 |
| SE7414855L (en) | 1975-07-10 |
| DK673174A (en) | 1975-09-01 |
| IE40205B1 (en) | 1979-04-11 |
| SE404376B (en) | 1978-10-02 |
| HU173914B (en) | 1979-09-28 |
| FI53983C (en) | 1978-09-11 |
| RO63768A (en) | 1978-12-15 |
| SU575038A3 (en) | 1977-09-30 |
| NL7500200A (en) | 1975-07-11 |
| ES433631A1 (en) | 1977-02-16 |
| ATA9575A (en) | 1977-01-15 |
| BE824104A (en) | 1975-07-07 |
| JPS5748198B2 (en) | 1982-10-14 |
| AT338970B (en) | 1977-09-26 |
| US3914218A (en) | 1975-10-21 |
| DD115917A5 (en) | 1975-10-20 |
| FI750038A (en) | 1975-07-10 |
| AR207344A1 (en) | 1976-09-30 |
| IL46268A0 (en) | 1975-05-22 |
| DE2500898A1 (en) | 1975-07-17 |
| CA1033674A (en) | 1978-06-27 |
| FR2256756A1 (en) | 1975-08-01 |
| IE40205L (en) | 1975-07-09 |
| LU71608A1 (en) | 1975-12-09 |
| JPS50100293A (en) | 1975-08-08 |
| PL94189B1 (en) | 1977-07-30 |
| DK137841B (en) | 1978-05-16 |
| AU7681374A (en) | 1976-06-24 |
| IL46268A (en) | 1977-06-30 |
| CS191924B2 (en) | 1979-07-31 |
| CH596311A5 (en) | 1978-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1496386A (en) | Antibiotics | |
| ES466791A1 (en) | Physiologically active substance esterastin | |
| AU565019B2 (en) | Cl-1557 antibiotic/antitumor compounds | |
| GB1491509A (en) | Metabolites s7481/f-1 and 1f-2 | |
| ES2010143A6 (en) | A new process for obtainment of Z(2R,5R)-3-(2-hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3,2,0)-heptane-2-carboxylic acid and pharmaceutically acceptable salts and esters thereof, from fermentation broths of Streptomyces sp. | |
| UA13320A (en) | The process for preparation of complex antibiotic cyclosporin and/or its components and the strain of fungus tolypocladium varium | |
| GB1478469A (en) | Ansamycin antibiotics produced by a species of micromonospora | |
| ES373632A1 (en) | Process for the preparation of daunorubicin | |
| GB1454735A (en) | Lincomycin production | |
| ES445965A1 (en) | Papulacandin derivatives and pharmaceutical compositions containing same | |
| EP0161849A3 (en) | Cl-1724 antibiotic-antitumour compounds, pharmaceutical compositions comprising the compounds and a novel microorganism for producing the compounds | |
| GB1314657A (en) | Antibiotics | |
| ES432549A1 (en) | Process for deacetoxycephalosporin c. | |
| GB1500965A (en) | Cyclic ether antibiotics | |
| GB1479179A (en) | Antibiotics designated xk-88 series and process for production thereof | |
| HUT50360A (en) | Process for producing antibiotic uk-61689 by microbiological way and pharmaceutical composition comprising the active ingredient and mycelium | |
| ES8504935A1 (en) | Antibiotic A51568 factors A and B. | |
| GB1367273A (en) | Production of rifamycin b | |
| IE32578B1 (en) | New process for the preparation of daunorubicin | |
| IE41079L (en) | Antibiotics a-28086 | |
| GB1382316A (en) | Fermentation for producing an antibiotic | |
| GB1438785A (en) | Antibiotics and a process for the preparation thereof | |
| EP0136923A3 (en) | 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof | |
| GB1318361A (en) | Method for preparation of a antifungal antibiotic | |
| GB1452457A (en) | Microbiological production of biologically active 8,8-bi-1h- naphthol-2,3-c-pyrans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |